Search Results - "Wranke, A"

Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy by Yurdaydin, Cihan, Abbas, Zaigham, Buti, Maria, Cornberg, Markus, Esteban, Rafael, Etzion, Ohad, Gane, Edward J., Gish, Robert G., Glenn, Jeffrey S., Hamid, Saeed, Heller, Theo, Koh, Christopher, Lampertico, Pietro, Lurie, Yoav, Manns, Michael, Parana, Raymundo, Rizzetto, Mario, Urban, Stephan, Wedemeyer, Heiner, Wranke, A., Pinheiro Borzacov, L.M., Lobato, C., Hamid, S., Ceausu, E., Dalekos, G.N., Turcanu, A., Niro, G.A., Lubna, F., Abbas, M., Ingiliz, P., Ferenci, P., Vanwolleghem, T., Hayden, T., Dashdorj, N., Motoc, A., Hardtke, S.

“…Chronic hepatitis delta represents the most severe form of chronic viral hepatitis. The current treatment of hepatitis delta virus (HDV) infection consists of…”
Get full text

Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis by Mettke, F., Schlevogt, B., Deterding, K., Wranke, A., Smith, A., Port, K., Manns, M. P., Vogel, A., Cornberg, M., Wedemeyer, H.

“…Summary Background Hepatitis C virus (HCV) clearance with IFN‐based therapies reduces the incidence of hepatocellular carcinoma (HCC). There has been some…”
Get full text

Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy by Lutterkort, G. L., Wranke, A., Hengst, J., Yurdaydin, C., Stift, J., Bremer, B., Hardtke, S., Keskin, O., Idilman, R., Manns, M. P., Dienes, H. P., Falk, C., Wedemeyer, H., Heidrich, B.

“…Summary Chronic hepatitis D is caused by coinfection of hepatitis B and hepatitis D virus. While HDV is the dominant virus over HBV in the majority of cases,…”
Get full text

Risk factors and seroprevalence of hepatitis E evaluated in frozen‐serum samples (2002‐2003) of pregnant women compared with female blood donors in a Southern region of Brazil by Hardtke, S., Rocco, R., Ogata, J., Braga, S., Barbosa, M., Wranke, A., Doi, E., da Cunha, D., Maluf, E., Wedemeyer, H., Muzzillo, D.

“…Hepatitis E has always been related to morbidity in pregnant women. Its epidemiology is not well understood in Brazil. Therefore, we tested sera from 209…”
Get full text

Interferon-free therapy of chronic hepatitis C does not change the short-term risk for de novo hepatocellular carcinomas in patients with liver cirrhosis by Mettke, F, Schlevogt, B, Deterding, K, Wranke, A, Port, K, Manns, M.P, Vogel, A, Cornberg, M, Wedemeyer, H

Get full text

A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study by Wedemeyer, H, Port, K, Deterding, K, Wranke, A, Kirschner, J, Bruno, B, Martins, B, Glenn, J.S, Kornberg, M, Manns, M.P

Get full text

Whole genome deep sequencing is superior to sequencing only regions of special interest for the characterization of HDV evolution by Wellhöner, F, Wranke, A, Barrantes, I, Plumeier, I, Bremer, B, Manns, M.P, Pieper, D.H, Wedemeyer, H, Heidrich, B, Heidrich, A.G

Get full text

P689 DIFFERENTIATION OF PATIENTS WITH HBeAg NEGATIVE HEPATITIS VERSUS HBeAg NEGATIVE INACTIVE CARRIER STATUS BY SERUM CYTOKINES AND CHEMOKINES by Wiegand, S.B, Wranke, A, Falk, C, Deterding, K, Manns, M.P, Wedemeyer, H, Cornberg, M

Get full text

P0565 : Cytokine patterns of patients with HCV/HBV co-infection by Wiegand, S.B, Wranke, A, Jaroszewicz, J, Potthoff, A, Deterding, K, Manns, M.P, Wedemeyer, H, Cornberg, M

Get full text

Non-Invasive Clinical Scores to Identify Liver Fibrosis in Hepatitis Delta Patients by Lutterkort, G.L, Wranke, A, Yurdaydin, C, Budde, E, Lichtinghagen, R, Stift, J, Hardtke, S, Idilman, R, Keskin, O, Koch, A, Manns, M.P, Dienes, H.P, Wedemeyer, H, Heidrich, B

Get full text

Does Antiviral Treatment Affect the Clinical Long-Term Outcome of Hepatitis Delta? by Wranke, A, Serrano, B.C, Heidrich, B, Kirschner, J, Bremer, B, Hardtke, S, Deterding, K, Port, K, Cornberg, M, Manns, M.P, Wedemeyer, H

Get full text

Diversity of clinical presentation and virological characteristics of hepatitis delta in different regions world-wide: results of the Hepatitis Delta International network by Wranke, A, Hardtke, S, Borzacov, L.M.P, Parana, R, Lobato, C, Hamid, S, Ceausu, E, Dalekos, G.N, Rizzetto, M, Turcanu, A, Niro, G, Hayden, T, Abbas, M, Ingiliz, P, Buti, M, Ferenci, P, Vanwolleghem, T, Motoc, A, Abbas, Z, Yurdaydin, C, Manns, M.P, Wedemeyer, H, Serrano, B.C, Wöbse, M, Heidrich, B, Muche, M, Gatselis, N.K, Zachou, K, Smedile, A, Gish, R, Obretin, D, Stern, R, Ho, E, Michielsen, P, Valentina, O.D, Lubna, F, Fontana, R

Get full text

P0638 : Global epidemiology of hepatitis delta: First data from the hepatitis delta international network by Hardtke, S, Abbas, Z, Hamid, S, Ceausu, E, Dalekos, G.N, Niro, G, Corti, G, Pinheiro Borzacov, L.M, Parana, R, Gatselis, N.K, Motoc, A, Ingiliz, P, Muche, M, Wranke, A, Wöbse, M, Yurdaydin, C, Manns, M.P, Wedemeyer, H

Get full text

435 ANTI-HDV-IgM AS A MARKER OF DISEASE ACTIVITY IN HEPATITIS DELTA by Wranke, A, Yurdaydin, C, Heidrich, B, Caruntu, F.A, Curescu, M.G, Yalcin, K, Gürel, S, Zeuzem, S, Erhardt, A, Lüth, S, Papatheodoridis, G.V, Bremer, B, Stift, J, Grabowski, J, Kirschner, J, Port, K, Cornberg, M, Falk, C, Dienes, H.P, Hardtke, S, Manns, M.P, Wedemeyer, H

Get full text

The interdisciplinary orthogeriatric ward round : Recommendations for the clinical routine by Heck, J, Ranker, A, Wranke, A, Kano, L, Macke, C, Rademacher, J, Stichtenoth, D O, Krause, O

“…An orthogeriatric co-management can improve the quality of care for geriatric trauma patients. The aim of this study was the establishment of treatment…”
Get full text

Long-term outcome of hepatitis delta compared to HBV monoinfection by Wranke, A., Deterding, K., Heidrich, B., Serrano, B.C., Kirschner, J., Bremer, B., Mix, C., Port, K., Cornberg, M., Manns, M.P., Wedemeyer, H.

Get full text

A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study by Wranke, A., Yurdaydin, C., Heidrich, B., Kalliopi, Z., Yalcin, K., Fehmi, T., Akarca, U., Lammert, F., Häussinger, D., Müller, T., Wöbse, M., Manns, M.P., Wedemeyer, H., Hardtke, S.

Get full text

FRI-288 - Long-term outcome of hepatitis delta compared to HBV monoinfection by Wranke, A., Deterding, K., Heidrich, B., Serrano, B.C., Kirschner, J., Bremer, B., Mix, C., Port, K., Cornberg, M., Manns, M.P., Wedemeyer, H.

Get full text

FRI-321 - A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study by Wranke, A., Yurdaydin, C., Heidrich, B., Kalliopi, Z., Yalcin, K., Fehmi, T., Akarca, U., Lammert, F., Häussinger, D., Müller, T., Wöbse, M., Manns, M.P., Wedemeyer, H., Hardtke, S.

Get full text

FRI-169 - Whole genome deep sequencing is superior to sequencing only regions of special interest for the characterization of HDV evolution by Wellhöner, F., Wranke, A., Barrantes, I., Plumeier, I., Bremer, B., Manns, M.P., Pieper, D.H., Wedemeyer, H., Heidrich, B., Heidrich, A.G.

Get full text